FDMT
#2613
4D Molecular Therapeutics, Inc. - Common Stock
13.0 0 USD
-0.02%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-2.48%
Monatliche Änderung
-4.69%
6 month change
+29.22%
Jahresänderung
+15.04%
Vorheriger Schlusskurs
13.3 3
Open
13.3 0
Tief
12.8 7
Hoch
13.4 7
Financials
2023
Current report, 09 Jan 2023
4D Molecular Therapeutics, Inc. current report, 09 January 2023
8-K
2022
Annual report, FY2022
4D Molecular Therapeutics, Inc. annual report, FY2022
10-K
Current report, 09 Nov 2022
4D Molecular Therapeutics, Inc. current report, 09 November 2022
8-K
Quarterly report, Q3 FY2022
4D Molecular Therapeutics, Inc. quarterly report, Q3 FY2022
10-Q
Current report, 23 Sep 2022
4D Molecular Therapeutics, Inc. current report, 23 September 2022
8-K
Current report, 11 Aug 2022
4D Molecular Therapeutics, Inc. current report, 11 August 2022
8-K
Quarterly report, Q2 FY2022
4D Molecular Therapeutics, Inc. quarterly report, Q2 FY2022
10-Q
Current report, 14 Jun 2022
4D Molecular Therapeutics, Inc. current report, 14 June 2022
8-K
Current report, 23 May 2022
4D Molecular Therapeutics, Inc. current report, 23 May 2022
8-K
Current report, 12 May 2022
4D Molecular Therapeutics, Inc. current report, 12 May 2022
8-K